First Jason explains how to deliver great investor updates & the benefits of doing them well (1:36). Then, Ginkgo Bioworks CEO Jason Kelly joins to discuss the expanding capabilities of synthetic biology (24:48), how Ginkgo is currently helping customers make products more effectively (35:58), the ethics & risks of editing DNA (51:53) & more!

Exploring the power of genetic engineering, the evolution of biotechnology into a $1 trillion industry, the potential of generative AI in synthetic biology, and China's ambitions in the biotech sector. Delving into the collaboration between the biotech industry and government for national security advancements, enhancing defense capabilities with biotech innovations, and the importance of regulatory frameworks in guiding biotech advancements. Wrapping up with a discussion on funding allocation, bridging biology and technology, and the transformative impact of biotechnology in various industries.

Jason Kelly, Co-founder and CEO of Ginkgo Bioworks, discusses using AI and DNA as code to revolutionize cell programming. Topics include bioengineering protein models, preparing for future pandemics, and the role of AI in synthetic biology.

Today John Cumbers talks with Jason Kelly, Co-founder and CEO of Ginkgo Bioworks. Together they will discuss synthetic biology’s coming of age” and get Jason’s take on several topics, such as the history of programmable biology, Sam Altman, Ai and the role of AI in biology, and the new congressional commission covering national security and emerging biotechnology. Check out this week's sponsor: Twist Bioscience Jason Kelly is a co-founder and the CEO of Ginkgo Bioworks. He obtained his doctorate in Bioengineering from MIT in 2008, where he worked on engineering bacteria to produce biofuels. In 2009, Kelly co-founded Ginkgo Bioworks along with four other co-founders. Under his leadership, Ginkgo has grown to become one of the leading companies in the field of synthetic biology, with a focus on developing custom microbes for a wide range of applications, including pharmaceuticals, agriculture, and industrial chemicals. Jason has been recognized for his contributions to synthetic biology, receiving several awards, including MIT Technology Review's Innovator Under 35 and Forbes' 30 Under 30 in Energy. Connect with Matt: @jrkelly Connect with John: @johncumbers Stay updated on the latest news in synthetic biology, check out our weekly newsletter, and follow us on social media: Twitter | LinkedIn | Facebook Be sure you make it to our SynBioBeta events! Click here for more information.

Join Bloomberg Originals correspondent Vanessa Perdomo, along with sports leaders Paul Caine, Wayne Kimmel, and F1 driver Pierre Gasly. They dive into the booming world of sports investing, revealing how technology is reshaping the landscape. Paul discusses creating premium event experiences, while Wayne highlights the enormous potential of sports travel packages. Jason chats with Pierre about athletes transitioning into ownership roles, emphasizing the economic rise of Formula 1 in the U.S. Exciting insights into how personal connections shape the competitive world of sports!

Crystal Tse, a Deals Reporter for Bloomberg News, analyzes Couche-Tard's monumental bid for the owner of 7-Eleven, highlighting the implications for the convenience store sector. Jason Kelly, Chief Correspondent at Bloomberg Originals, dives into NFL players' struggles with sports betting regulations and the economic landscape they navigate. Avi Hasson, CEO of Startup Nation Central, discusses the resilience of Israel's economy amidst conflict and how innovation continues to thrive in challenging times.

Bloomberg's experts delve into Amazon's shareholder letter, the value of public school education, and insights on Constellation earnings. A-Rod and Jason Kelly chat about workplace dynamics and the challenges in women's sports broadcasting.

The podcast features intimate conversations with business titans, sports champions, and entrepreneurs discussing investment philosophies and career moves. Topics include challenges in financial services, decision-making on Gen AI technology, upskilling, talent hunt, and budget constraints.

Exploration of deal making in sports, media, and entertainment with exclusive interviews with Maria Sharapova and Michael Strahan. Insights into sports business deals and athlete experiences, showcasing benefits of long-term contracts and diverse content.

The podcast features conversations with business titans and sports champions, discussing investment philosophies and career moves. Topics include virtual reality training, climate solutions, and business icons in sports and entertainment.